Silica Gel Column Chromatography: How It Works and How to Choose the Silica

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica for Refractory: Types, Properties and High-Temperature Applications
  • Keywords: silica supplier Brazil
  • Published: 2026-11-20 14:37:53
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Top Silica Manufacturers in the World: 2026 List and Comparison

Silica Gel Desiccant: How It Works, Types, Capacity and How to Choose
Lyophilization can be safely used for heat-sensitive drug substances because the drug is formulated at low temperatures and low pressure. Another advantage compared to direct compression is that the poor flowability does not cause problems here, and the pore structure of the nanoparticle is not damaged in the absence of compression. The freeze-drying process can be divided into three main steps: freezing, primary drying, and secondary drying [ 101 ]. The loaded carriers are homogenized with the prepared polymer solution [ 102, 103 ], containing matrix agents (PEG, polyvinyl alcohol (PVA), hydroxyethyl cellulose (HEC), polyvinylpyrrolidone (PVP), alginate, dextran), cryoprotectants (sucrose, or sugar alcohols such as mannitol, sorbitol), surfactants (polysorbates, sorbitan monooleate), super disintegrants (croscarmellose sodium) [ 102 ]. The resulting dispersion is filled into blisters and then lyophilized [ 102, 103 ]. During the process, the desired tablet shape is formed, adapting to the shape of the blister [ 102 ]. They are characterized by rapid disintegration (less than 30 s), low moisture content, and rapid dissolution [ 41, 102, 103 ]. Elmowafy et al. effectively optimized lyophilized tablet formulations using quercetin-loaded MSN carriers [ 41 ]. PVP-K30 was used as a polymeric stabilizer, PEG 6000 as a co-binding polymer, and sucrose as a cryoprotectant. This freeze-dried formulation permits fast disintegration and low friability (less than 1%). Importantly, the saturation solubility and the dissolution rate, and so the oral bioavailability of the poorly water-soluble quercetin boosted particularly, and it can be further improved by sublingual application [ 41 ]. Utilizing the right composition, an orally dispersible tablet can be produced, which is why its sublingual use is advantageous, because the API goes directly into the systemic circulation (bypassing the enteral circulation, so the first pass impact does not apply), hence improving oral bioavailability [ 41, 100 ]. Besides immediate drug release, sustained and even targeted drug release is also available, provided by appropriate formulation, thus increasing the therapeutic possibilities. These days, gastroretentive and mucoadhesive freeze-dried tablets are also available, further broadening the spectrum [ 102, 103 ].
Mica Powder vs Silica: Properties and Applications Compared
MSNs are also appropriate for pulmonary drug delivery. Inhalation is an attractive route of administration since the application is non-invasive and patient-friendly [ 18 ]. However, the rapid mucociliary clearance and the mucus hurdle complicate the intake of the API and are obstacles to be overcome [ 18, 25 ]. The mesoporous drug delivery systems may be really helpful in the treatment of lung diseases, as they can passively accumulate in the alveoli [ 25, 56, 72 ]. The passive accumulation is due to their small size, while the sizable surface area, high vascularity, and vascular permeability of the lungs enhance the process [ 56 ]. Furthermore, targeted treatment of tumors or inflamed cells can also be implemented with the functionalization of their surface [ 56, 72 ]. MSNs are typically delivered to the lungs in powder form with dry powder inhalers or suspended in liquid droplets with a nebulizer [ 56 ].
What Is the Molar Mass of Silicon Dioxide (SiO₂)? Calculation Explained
Tablets are the most used solid dosage form because of their numerous perks. They are characterized by excellent physical and chemical stability, high patient compliance, and productive economic production [ 92 ]. The incorporation of silica nanocarriers in tablet production presents a modern and innovative solution to diverse hurdles, boosting both the manufacturing process and therapeutic effectiveness. One of the considerable benefits of mesoporous silica carriers is their ability to stabilize the API in an amorphous state, which greatly improves its solubility [ 30, 39, 42, 43, 92 ]. This enhancement brings about a considerable increase in the dissolution rate of tablets, thereby improving bioavailability and resulting in more effective therapy [ 30, 39, 42, 92 ]. Furthermore, nanocarriers can effectively mask the bitter taste and unpleasant odor of the API, potentially further boosting patient compliance [ 42, 93 ]. Zhang et al. observed a considerable improvement in oral bioavailability with Telmisartan-loaded MSN carriers in vivo absorption studies conducted on dogs [ 24 ]. This MSN-containing tablet formulation was compared to commercially available tablets, with notable improvements attributed chiefly to the boosted permeability and solubility provided by the nanocarriers [ 24 ]. Moreover, the physical and chemical stability of the API may also improve, which is especially advantageous for sensitive molecules [ 39, 92 ].
What Is Silicon Dioxide (SiO₂)? Structure, Properties, Types and Uses Explained
MSNs are SiO 2 nanoparticles [ 2 ] with a pore diameter between 2 and 50 nm [ 3, 4 ] and with a total diameter of a maximum of 1 µm. Their use in drug delivery dates to the early 1990s when they were synthesized for various scientific applications [ 5 ]. The material known as mesoporous silica was discovered by Mobil Oil Corporation in 1992 [ 6 ]. Their first drug delivery application was demonstrated in 2001 when MCM-41 silica was used to release ibuprofen [ 7 ]. Since then, MSNs have become an increasingly popular drug delivery system due to their advantageous properties and have been typically recognized as secure (GRAS) by the FDA. Tiny SNPs have been approved for human clinical imaging studies, setting the stage for their use in clinical applications of drug delivery. The number of related research activities is continuously increasing each year, expanding their role in cancer treatment, gene delivery, and oral illness therapy [ 5 ]. Their pore size is located between microporous and macroporous systems. They can be used in diverse shapes (sphere, cube, ellipsoid, rod) and sizes, with different pore sizes and pore structures [ 2, 3, 4, 8, 9, 10 ]. They have a high degree of stability [ 8 ] and a rigid framework, which results in resistance to temperature, pH, enzymatic degradation, and mechanical force [ 4 ]. Thanks to the large number of pores, they have a massive particular surface region (approx. 700-1300 m 2 /g) and pore volume (approx. 0.5-1.5 cm 3 /g), which enables effective adsorption of diverse molecules [ 2, 3, 4, 8, 9, 10 ]. By changing the pore size distribution, the range of adsorbable molecules can be controlled [ 3 ], which also lets separation based on size exclusion, which means selective adsorption of molecules of certain sizes. Depending on the size of the pores, tiny molecules together with high molecular weight proteins can be transported into the pores [ 8 ]. In addition, chemical separation is also possible if the surface of the pores is coated with specific functional groups [ 4 ], which enables the separation of the APIs according to their structure [ 4 ]. Such modifications may include the setting of hydrophilicity/hydrophobicity of the surface, depending on whether the adsorption of hydrophobic or hydrophilic molecules is targeted [ 4 ]. By inserting different functional groups, the surface charge can also be controlled so that certain molecules will bind more efficiently. MSNs have a negative surface charge in biological environments, which promotes the electrostatic adsorption of positively charged APIs in the pores [ 10 ]. Moreover, the biological markers attached to the surface of the nanoparticles enable the drug-carrying system to deliver the API in a tissue-specific manner [ 2, 4, 8, 9, 10 ]. A substantial problem is the premature release of the API from the pores during transport [ 4, 8 ], which can be solved by utilizing gatekeepers that respond to special stimuli and keep the pores closed until the stimulus [ 2, 4, 8 ]. In this way, controlled drug delivery and stimuli-responsive release can be achieved [ 2, 4, 9 ]. The drug release could be triggered by temperature, pH, redox potential, light, enzymes, magnetic field, or different ligands [ 4, 8, 11 ].

What Is Silica Gel? How It Works, Types and Uses as a Desiccant and Adsorbent

What is silica (SiO₂)?

quartz sand supplier Certain molecules have an excessive adhesive property, and this represents another problem to be eliminated during direct tableting. In this case, a tiny amount of powder adheres to the surface of the upper- and lower punch or the die during each compression cycle [ 94 ]. Therefore, tablet weight changes, and tablets with an uneven surface are obtained. More importantly, this may bring about poor content uniformity due to API loss. By contrast, if the greatly adhesive API is enclosed in the pores of the silica carrier, direct contact with the metal parts is eliminated. Thus, the loss of the API can be avoided [ 92, 94 ].

What is the difference between fumed silica and precipitated silica?

best silica supplier

What drives silica raw material prices?

silica flow agent 45. Knapik-Kowalczuk J., Kramarczyk D., Chmiel K., Romanova J., Kawakami K., Paluch M. Importance of mesoporous silica particle size in the stabilization of amorphous pharmaceuticals - The case of simvastatin. Pharmaceutics. 2020;12:384. doi: 10.3390/pharmaceutics12040384. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]

Cite this article: Silica Raw Materials News. "Talc Powder vs Silica: Differences and Which Filler to Choose ." Published 2026-11-20 14:37:53. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.